These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Completed, but no date 2008-000547-34 Lenalidomide for Myelodysplastic Syndromes: Efficacy, Safety, Cardiac Changes, and Quality of Life (QoL-ESC RevMDS) bad-data
Ongoing 2010-019710-24 A Randomized Study to Evaluate the Efficacy of 5-Aza for Post-Remission Therapy of Acute Myeloid Leukemia in Elderly Patients (QoLESS AZA-AMLE) not-yet-due
Ongoing 2010-022890-33 Eltrombopag for the treatment of thrombocytopenia due to low- and intermediate risk myelodysplastic syndromes. not-yet-due
Listed as ongoing, but also has a completion date 2015-000362-53 Efficacy of eltrombopag plus lenalidomide combination therapy in patients with IPSS low and intermediate-risk myelodysplastic syndrome with isolated del5q: a multicenter, randomized, double-blind, pla... 2018-09-19 bad-data